pharma · Locally advanced or metastatic urothelial cancer · Nectin-4 Expressing Advanced Malignancies. · BCYC
BICYCLE THERAPEUTICS
BICYCLE THERAPEUTICS trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Cambridge, GB HQ
2009 Founded
282 Employees
Public company Type
BCYC · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, GB
- Founded
- 2009
- Employees
- 282
- Programs
- 8
- Drugs
- 15
- Patents
- 57
BICYCLE THERAPEUTICS clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to BICYCLE THERAPEUTICS programs — each row shows trial ID, program name, phase, status, and indication.
BICYCLE THERAPEUTICS trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for BICYCLE THERAPEUTICS.
-
BT8009-230 — Phase 3
Clinical update -
BT8009-230 — Phase 3
Clinical update -
BT8009-100 — Phase 2
Clinical update -
buprenorphine/naloxone — Approved
Clinical update -
Zelenectide Pevedotin, BT8009 — Phase 2
Clinical update -
BT8009, Zelenectide Pevedotin — Phase 2
Clinical update -
NIVOLUMAB, BT5528 — Phase 2
Clinical update -
BT1718 — Phase 2
Clinical update